Cefuroxime-d3

CAT:
804-HY-B1256S
Size:
1 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Cefuroxime-d3 - image 1

Cefuroxime-d3

  • Description:

    Cefuroxime-d3 is deuterium labeled Cefuroxime (sodium) . Cefuroxime sodium is an orally active second-generation cephalosporin antibiotic with increased stability to β-lactamase. Cefuroxime sodium has a broad spectrum activity against Gram-positive and Gram-negative bacteria[1].
  • UNSPSC:

    12352005
  • Hazard Statement:

    H302-H315-H319-H335
  • Target:

    Antibiotic; Bacterial; Isotope-Labeled Compounds
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Anti-infection; Others
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Infection
  • Solubility:

    10 mM in DMSO
  • Smiles:

    OC (C1=C (COC (N) =O) CS[C@@] ([C@@H]2NC (/C (C3=CC=CO3) =N\OC ([2H]) ([2H]) [2H]) =O) ([H]) N1C2=O) =O
  • Molecular Formula:

    C16H13D3N4O8S
  • Molecular Weight:

    427.40
  • Precautions:

    P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Callaghan, et al. Cefuroxime sodium, a New Cephalosporin Antibiotic: Activity in Vitro. Antimicrob Agents Chemother. 1976 Mar;9 (3) :511-9.|[3]D M Ryan, et al. Cefuroxime sodium, a New Cephalosporin Antibiotic: Activity in Vivo. Antimicrob Agents Chemother. 1976 Mar;9 (3) :520-5.
  • Shipping Conditions:

    Room temperature
  • Scientific Category:

    Isotope-Labeled Compounds
  • Clinical Information:

    No Development Reported
  • Isoform:

    β-lactam
  • CAS Number:

    1803240-98-3